Turkeys may provide potentially life-saving antibiotic

Image
Press Trust of India Washington
Last Updated : Nov 26 2014 | 4:06 PM IST
Scientists have discovered that the biological machinery needed to produce a potentially life-saving antibiotic is found in turkeys.
Researchers from Brigham Young University found that the antibiotic to target staph infections and strep throat can come from good bacteria in turkeys.
"The good bacteria we're studying has been keeping turkey farms healthy for years and it has the potential to keep humans healthy as well," said BYU microbiologist Joel Griffitts.
The good bacteria, Strain 115 as scientists know it, produces the MP1 antibiotic - a known killer that could target staph infections, strep throat, severe gastrointestinal diseases and roughly half of all infectious bacteria.
This antibiotic, however, is not in widespread use because of its complex structure.
Researchers have used mass spectrometry and nuclear magnetic resonance spectroscopy to identify exactly how Strain 115 makes this antibiotic and how it manages to do so without killing itself.
They found the engine inside of Strain 115, a compact DNA molecule also known as a plasmid, produces both the killer antibiotic and a self-protecting agent.
It makes a "spare" ribosome part which, when inserted into a normal ribosome, renders it immune to the antibiotic.
Strain 115 was discovered by now-retired BYU professor Marcus Jensen at a turkey farm more than three decades ago.
Through his research on the strain, Jensen went on to develop three vaccines vital to the prevention of diseases in turkeys.
While his work with turkeys became widely known and led to awards, his research moved in new directions and the strain was set aside in 1983.
Some 30 years later, a student found the strain in a freezer. After some initial research efforts, graduate student Philip Bennallack took the project into high gear.
The group has published their findings in the Journal of Bacteriology.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 26 2014 | 4:06 PM IST

Next Story